As key regulators of tumor immune evasion, high LGALS1 expression in AML patients was associated with higher macrophages M2, monocytes infiltration, and lower naive T cells CD4, naive B cells, and resting mast cells infiltration, which remained consistent with a previous study (Tribulatti et al., 2012). The gene discussed is LGALS1; the disease is neoplasm.